Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Pediatric Radiology
Erschienen in: Pediatric Radiology 11/2019

01.10.2019 | Pediatric oncologic imaging

Functional and anatomical imaging in pediatric oncology: which is best for which tumors

verfasst von: Stephan D. Voss

Erschienen in: Pediatric Radiology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Functional imaging techniques are playing an increasingly important role in the management of pediatric cancer. Technological advances have pushed the development of hybrid imaging techniques, including positron emission tomography (PET)/CT, PET/MR and single-photon emission computed tomography (SPECT)/CT. Together with an increasing need to identify surrogate biomarkers for response to novel therapies, the use of functional imaging techniques, which had been reserved primarily for lymphoma patients, is now being recognized as standard of care for the management of many other pediatric solid tumors. The purpose of this review is to summarize recent data describing the use of functional and metabolic imaging strategies for the staging and response assessment of common pediatric solid tumors, and to offer some guidance as to which techniques are most appropriate for which tumor types.
Literatur
1.
Brisse HJ, McCarville MB, Granata C et al (2011) Guidelines for imaging and staging of neuroblastic tumors: consensus report from the international neuroblastoma risk group project. Radiology 261:243–257CrossRefPubMed
2.
Dumba M, Jawad N, McHugh K (2015) Neuroblastoma and nephroblastoma: a radiological review. Cancer Imaging 15(5)
3.
Kembhavi SA, Rangarajan V, Shah S et al (2014) Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours. Clin Radiol 69:900–908CrossRefPubMed
4.
Parisi MT, Eslamy H, Park JR et al (2016) (1)(3)(1)I-metaiodobenzylguanidine theranostics in neuroblastoma: historical perspectives; practical applications. Semin Nucl Med 46:184–202CrossRefPubMed
5.
Park JR, Bagatell R, Cohn SL et al (2017) Revisions to the international neuroblastoma response criteria: a consensus statement from the National Cancer Institute clinical trials planning meeting. J Clin Oncol 35:2580–2587CrossRefPubMedPubMedCentral
6.
Pfluger T, Piccardo A (2017) Neuroblastoma: MIBG imaging and new tracers. Semin Nucl Med 47:143–157CrossRefPubMed
7.
Sharp SE, Trout AT, Weiss BD et al (2016) MIBG in neuroblastoma diagnostic imaging and therapy. Radiographics 36:258–278CrossRefPubMed
8.
DuBois SG, Mody R, Naranjo A et al (2017) MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: a report from the Children's oncology group. Pediatr Blood Cancer 64
9.
Gauguet JM, Pace-Emerson T, Grant FD et al (2017) Evaluation of the utility of (99m) Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma. Pediatr Blood Cancer 64
10.
Bleeker G, Tytgat GA, Adam JA et al (2015) 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma. Cochrane Database Syst Rev (2015):CD009263
11.
Matthay KK, Shulkin B, Ladenstein R et al (2010) Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the international neuroblastoma risk group (INRG) task force. Br J Cancer 102:1319–1326CrossRefPubMedPubMedCentral
12.
Yanik GA, Parisi MT, Naranjo A et al (2018) Validation of postinduction curie scores in high-risk neuroblastoma: a Children's oncology group and SIOPEN group report on SIOPEN/HR-NBL1. J Nucl Med 59:502–508CrossRefPubMedPubMedCentral
13.
Ladenstein R, Lambert B, Potschger U et al (2018) Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials. Eur J Nucl Med Mol Imaging 45:292–305CrossRefPubMed
14.
15.
Flood TF, Stence NV, Maloney JA et al (2017) Pediatric brain: repeated exposure to linear gadolinium-based contrast material is associated with increased signal intensity at unenhanced T1-weighted MR imaging. Radiology 282:222–228CrossRefPubMed
16.
Goischke HK (2017) Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues. Mult Scler J Exp Transl Clin 3:2055217317704450PubMedPubMedCentral
17.
Callahan MJ, MacDougall RD, Bixby SD et al (2018) Ionizing radiation from computed tomography versus anesthesia for magnetic resonance imaging in infants and children: patient safety considerations. Pediatr Radiol 48:21–30CrossRefPubMed
18.
Towbin AJ, Meyers RL, Woodley H et al (2018) 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric hepatic international tumour trial (PHITT). Pediatr Radiol 48:536–554CrossRefPubMed
19.
Mody RJ, Pohlen JA, Malde S et al (2006) FDG PET for the study of primary hepatic malignancies in children. Pediatr Blood Cancer 47:51–55CrossRefPubMed
20.
Cistaro A, Treglia G, Pagano M et al (2013) A comparison between (1)(8)F-FDG PET/CT imaging and biological and radiological findings in restaging of hepatoblastoma patients. Biomed Res Int 2013:709037CrossRefPubMedPubMedCentral
21.
Begent J, Sebire NJ, Levitt G et al (2011) Pilot study of F(18)-fluorodeoxyglucose positron emission tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry. Eur J Cancer 47:389–396CrossRefPubMed
22.
Moinul Hossain AK, Shulkin BL, Gelfand MJ et al (2010) FDG positron emission tomography/computed tomography studies of Wilms' tumor. Eur J Nucl Med Mol Imaging 37:1300–1308CrossRefPubMedPubMedCentral
23.
Provenzi M, Saettini F, Conter V et al (2013) Is there a role for FDG-PET for the assessment of treatment efficacy in Wilms' tumor? A case report and literature review. Pediatr Hematol Oncol 30:633–639CrossRefPubMed
24.
Harrison DJ, Parisi MT, Shulkin BL (2017) The role of (18)F-FDG-PET/CT in pediatric sarcoma. Semin Nucl Med 47:229–241CrossRefPubMed
25.
Hurley C, McCarville MB, Shulkin BL et al (2016) Comparison of (18) F-FDG-PET-CT and bone scintigraphy for evaluation of osseous metastases in newly diagnosed and recurrent osteosarcoma. Pediatr Blood Cancer 63:1381–1386CrossRefPubMedPubMedCentral
26.
Croteau NJ, Heaton TE (2019) Pulmonary metastasectomy in pediatric solid tumors. Children 6
27.
McCarville MB, Billups C, Wu J et al (2013) The role of PET/CT in assessing pulmonary nodules in children with solid malignancies. AJR Am J Roentgenol 201:W900–W905CrossRefPubMedPubMedCentral
28.
Byun BH, Kong CB, Lim I et al (2014) Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential (1)(8)F-FDG PET/CT and MRI. Eur J Nucl Med Mol Imaging 41:1553–1562CrossRefPubMed
29.
Hawkins DS, Conrad EU 3rd, Butrynski JE et al (2009) [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer 115:3519–3525CrossRefPubMed
30.
Sharp SE, Shulkin BL, Gelfand MJ et al (2017) FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients. Pediatr Radiol 47:1800–1808CrossRefPubMed
31.
Hawkins DS, Schuetze SM, Butrynski JE et al (2005) [18F] fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 23:8828–8834CrossRefPubMed
32.
Uslu L, Donig J, Link M et al (2015) Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies. J Nucl Med 56:274–286CrossRefPubMed
33.
Federico SM, Spunt SL, Krasin MJ et al (2013) Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcoma. Pediatr Blood Cancer 60:1128–1134CrossRefPubMed
34.
Borinstein SC, Steppan D, Hayashi M et al (2018) Consensus and controversies regarding the treatment of rhabdomyosarcoma. Pediatr Blood Cancer 65
35.
Alcorn KM, Deans KJ, Congeni A et al (2013) Sentinel lymph node biopsy in pediatric soft tissue sarcoma patients: utility and concordance with imaging. J Pediatr Surg 48:1903–1906CrossRefPubMed
36.
Wagner LM, Kremer N, Gelfand MJ et al (2017) Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging — a prospective trial. Cancer 123:155–160CrossRefPubMed
37.
Casey DL, Wexler LH, Fox JJ et al (2014) Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys 90:1136–1142CrossRefPubMed
38.
Mueller WP, Melzer HI, Schmid I et al (2013) The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis. Eur J Nucl Med Mol Imaging 40:356–363CrossRefPubMed
39.
Kim JR, Yoon HM, Jung AY et al (2019) Comparison of whole-body MRI, bone scan, and radiographic skeletal survey for lesion detection and risk stratification of Langerhans cell histiocytosis. Sci Rep 9:317CrossRefPubMedPubMedCentral
40.
Nievelstein RA, Littooij AS (2016) Whole-body MRI in paediatric oncology. Radiol Med 121:442–453CrossRefPubMed
41.
Phillips M, Allen C, Gerson P et al (2009) Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 52:97–101CrossRefPubMed
42.
Tsai LL, Drubach L, Fahey F et al (2012) [18F]-fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation. J Neuro-Oncol 108:469–475CrossRef
43.
Benz MR, Czernin J, Dry SM et al (2010) Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer 116:451–458CrossRefPubMed
44.
Evans DGR, Salvador H, Chang VY et al (2017) Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1. Clin Cancer Res 23:e46–e53CrossRefPubMed
45.
Malempati S, Weigel B, Ingle AM et al (2012) Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's oncology group. J Clin Oncol 30:256–262CrossRefPubMed
46.
Mosse YP, Voss SD, Lim MS et al (2017) Targeting ALK with crizotinib in pediatric anaplastic large cell lymphoma and inflammatory myofibroblastic tumor: a Children's oncology group study. J Clin Oncol 35:3215–3221CrossRefPubMedPubMedCentral
47.
Kong G, Hofman MS, Murray WK et al (2016) Initial experience with gallium-68 DOTA-octreotate PET/CT and peptide receptor radionuclide therapy for pediatric patients with refractory metastatic neuroblastoma. J Pediatr Hematol Oncol 38:87–96CrossRefPubMed
48.
Paterson BM, Roselt P, Denoyer D et al (2014) PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate. Dalton Trans 43:1386–1396CrossRefPubMed
49.
Pandit-Taskar N, Zanzonico P, Staton KD et al (2018) Biodistribution and dosimetry of (18)F-meta-fluorobenzylguanidine: a first-in-human PET/CT imaging study of patients with neuroendocrine malignancies. J Nucl Med 59:147–153CrossRefPubMedPubMedCentral
Metadaten
Titel
Functional and anatomical imaging in pediatric oncology: which is best for which tumors
verfasst von
Stephan D. Voss
Publikationsdatum
01.10.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 11/2019
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-019-04489-z

Weitere Artikel der Ausgabe 11/2019

Pediatric Radiology 11/2019 Zur Ausgabe

Pediatric oncologic imaging

The Children’s Oncology Group: an opportunity for pediatric radiologists

Pediatric oncologic imaging

Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma

Pediatric oncologic imaging

Imaging of Wilms tumor: an update

Pediatric oncologic imaging

Overview of the clinical and imaging features of the most common non-rhabdomyosarcoma soft-tissue sarcomas

Pediatric oncologic imaging

Introduction

Pediatric oncologic imaging

Ovarian neoplasms of childhood

Neu im Fachgebiet Radiologie

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise